Erik Dubberke

Clinical Director of the Transplant Infectious Diseases Consult Service · Washington University/B-JH/SLCH Consortium

Credentials: · · · · ·

History

Transplant Infectious Diseases Consult Service · Washington University/B-JH/SLCH Consortium
Present
Infectious Diseases Epidemiology Research · Washington University/B-JH/SLCH Consortium
Present
infection Prevention and Control at Missouri Baptist Medical Center Hospital · Washington University/B-JH/SLCH Consortium
Present

Multi-Omics Unit for Combating Antibiotic-Resistant Bacteria (MOCARB)
National Institute of Allergy and Infectious Diseases · P01
PI · $2.2M · Washington University
2026–2031
Phase 1b/2a Evaluation of the Safety and Tolerability of SYN-004 in Adult Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) Recipients
National Institute of Allergy and Infectious Diseases · U01
Contact PI · $919.8K · Washington University
2026–2031
High-Resolution Genomic Interrogation of Pathogen-Microbiome Interactions in Clostridioides Difficile Infection
National Institute of Allergy and Infectious Diseases · R01
PI · $2.3M · Washington University
2024–2029
Culturomic and Metagenomic Methods Optimization to Detect Multi-Strain C. difficile Colonization and Infection
National Institute of Allergy and Infectious Diseases · R21
Contact PI · $427.6K · Washington University
2025–2027

Fecal Microbiota Transplantation (FMT) for MDRO UTI
Principal investigator · Completed · Phase 1, Phase 2
Washington University School of Medicine
2018–2021
TOX NEG Trial: Clostridium Difficile Diagnosis and Treatment
Principal investigator · Completed · Phase 4
Washington University School of Medicine
2017–2021
FMT for Multidrug Resistant Organism Reversal
Principal investigator · Completed · Phase 1
Washington University School of Medicine
2015–2020